Jordi Remon, Tina Cascone, Solange Peters. "Erratum: BR.31 Trial: Adjuvant Durvalumab as the Third Contender in Resected Non–Small Cell Lung Cancer." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco-26-00221